Creative Planning Rhythm Pharmaceuticals, Inc. Transaction History
Creative Planning
- $116 Billion
- Q2 2025
A detailed history of Creative Planning transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Planning holds 17,222 shares of RYTM stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,222
Previous 12,333
39.64%
Holding current value
$1.7 Million
Previous $653,000
66.62%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RYTM
# of Institutions
244Shares Held
63.8MCall Options Held
311KPut Options Held
522K-
Black Rock Inc. New York, NY6.74MShares$666 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$554 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$550 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$482 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$355 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.51B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...